Press Release

Announces Increased Orders

Medical Holdings, Inc. Littleton, Colorado (OTCBB: ZYNX),

provider of pain management systems and electrotherapy products for medical

patients with functional disability, announces an increase in its orders of

for January of 2007 compared to the same month last year and a 172% increase

of 2006, compared to the 4th

Sandgaard, CEO, states: "We are pleased to see that our expanded sales force

continues to increase sales and rentals and leverage their industry experience

to keep building a significant position in the market for Zynex. We expect

see an increase in orders in the foreseeable future when compared to the same

received 590 orders in January, 2007 versus 135 orders twelve months ago and

of 2006 versus 378 orders in the 4th

of 2005, respectively.

not yet finalized its results for the fourth quarter of 2006 and the 2006 year,

including the impact of increased sales and rentals. Zynex will state these

results in the Form 10-KSB for the 2006 year.

Zynex Medical Holdings, Inc.

Medical Holdings, Inc. (founded in 1996) engineers, manufactures, markets and

sells its own design of electrotherapy medical devices in two distinct markets:

standard digital electrotherapy products for pain relief and pain management;

and the NeuroMove(TM) for stroke and spinal cord injury (SCI) rehabilitation.

Zynex's product lines are fully developed, FDA-cleared, commercially sold,

have been developed to uphold the Company's mission of improving the quality

life for patients suffering from impaired mobility due to stroke, spinal cord

injury, or debilitating and chronic pain.

statements in this release are "forward-looking" and as such are subject to

numerous risks and uncertainties. Actual results may vary significantly from

results expressed or implied in such statements. Factors that could cause actual

results to materially differ from forward-looking statements include, but are

not limited to, risks and delays associated with product development, risk

market acceptance of products, technology or product obsolescence, competitive

risks, reliance on manufacturing partners, dependence on reimbursement from

insurance companies, additional capital needs and other risks described in

Form 10-KSB for the year ended December 31, 2005.